Another interesting study showed that the combination treatment of cells that were RB1 wildtype with MYCN amplification and chemoresistant with Panobinostat and bortezomib or carboplatin inhibited tumor cell growth [5]. The gene discussed is MYCN; the disease is neoplasm.